Opioid Peptide Pharmacology
Endogenous opioid peptides including endorphins, enkephalins, and dynorphins modulate pain, mood, and reward through mu, delta, and kappa receptors. Understanding their pharmacology is key to pain management and addiction research.
The Endogenous Opioid System
The body produces its own opioid peptides that regulate pain perception, emotional responses, and reward pathways. Three major families of endogenous opioids exist: endorphins, enkephalins, and dynorphins. Each family has distinct receptor preferences and physiological roles.
The Three Peptide Families
Beta-endorphin is a 31-amino acid peptide derived from pro-opiomelanocortin (POMC). It has high affinity for mu-opioid receptors and is released during stress, exercise, and pain. Beta-endorphin produces profound analgesia and euphoria, contributing to the runner’s high phenomenon.
Enkephalins (Met-enkephalin and Leu-enkephalin) are pentapeptides derived from proenkephalin. They preferentially bind delta-opioid receptors and are distributed widely in the brain and spinal cord. Enkephalins modulate pain at the level of the dorsal horn and influence emotional behavior.
Dynorphins (Dynorphin A, Dynorphin B) are derived from prodynorphin and preferentially activate kappa-opioid receptors. Dynorphins are found in the hypothalamus, hippocampus, and spinal cord. They play roles in pain modulation, stress responses, and diuresis.
Receptor Pharmacology
The three main opioid receptors are all G-protein coupled receptors:
- Mu (MOR): Analgesia, respiratory depression, euphoria, dependence
- Delta (DOR): Analgesia, mood regulation, antidepressant effects
- Kappa (KOR): Analgesia, dysphoria, sedation
Most endogenous opioids share the conserved N-terminal sequence Tyr-Gly-Gly-Phe, which is essential for receptor binding. The tyrosine residue mimics the pharmacophore of morphine and related alkaloids.
Mnemonic: “MED” for the receptor families
Remember the receptor families with “MED”: Mu, E (for enkephalins and delta), Dynorphins (kappa). Or associate each: Mu with Morphine-like effects, Delta with Depression of mood (delta modulates emotion), Kappa with Keen awareness (dynorphins produce dysphoria, an altered mental state).
Clinical Significance
Synthetic opioids like fentanyl target mu receptors with high potency. Understanding endogenous opioid pharmacology helps explain why opioid addiction develops through receptor downregulation and why kappa agonists might serve as alternative analgesics without the same dependence risk.